专利号:US-6630602-B1 优先权日:1998-04-16 标题 :Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them 发明人:BIALER MEIR; SPIGELSTEIN OFER; YAGEN BORIS 权利人:YISSUM RES DEV CO 摘要:The present invention relates to racemic propylisopropyl acetic acid and propylisopropyl acetamide and their isomers in their racemic and stereospecific forms, for use in treatment of neurological and psychotic disorders, and affective disorders and to treat pain, headaches and migraines. The isomers are of the compound formula I:wherein R1 is a methyl or ethyl group; R2 is H, methyl or an ethyl group; R3 is ethyl or a propyl group; and R4 is a hydroxyl or amide group; and the total number of carbon atoms in said compound is 8, provided that when R1 is a methyl group and R4 is an amide group, R2 and R3 are not ethyl, further provided that when R1 is an ethyl and R4 a hydroxyl group, only stereoisomers of the compound are referred to. The present invention further relates to a method for the stereoselective synthesis of the 2S and 2R stereoisomer of PID and PIA. The present invention also relates to pharmaceutical compositions containing as an active ingredient a racemic mixture or stereoisomers of the compounds of the general formula (I), which are useful for the treatment of neurological and psychotic disorders, and affective disorders and to treat pain, headaches and migraines.
专利号:US-6969732-B2 优先权日:1999-04-12 标 题 :Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them 发明人:BIALER MEIR; SPIGELSTEIN OFER; YAGEN BORIS 权利人:YISSUM RES DEV CO 摘要:The present invention relates to racemic propylisopropyl acetic acid and propylisopropyl acetamide and their isomers in their racemic and stereospecific forms, for use in treatment of neurological and psychotic disorders, and affective disorders and to treat pain, headaches and migraines. The isomers are of the compound formula I n n R 1 is a methyl or ethyl group; R 2 is H, methyl or an ethyl group; R 3 is ethyl or a propyl group; and R 4 is a hydroxyl or amide group,n nand the total number of carbon atoms in said compound is 8, provided that when R1 is a methyl group and R4 is an amide group, R2 and R3 are not ethyl, further provided that when R1 is an ethyl and R4 a hydroxyl group, only stereoisomers of the compound are referred to.n nn The present invention further relates to a method for the stereoselective synthesis of the 2R stereoisomer of PID and PIA. The present invention also relates to pharmaceutical compositions containing as an active ingredient a racemic mixture or stereoisomers of the compounds of the general formula (I), which are useful for the treatment of neurological and psychotic disorders, and affective disorders and to treat pain, headaches and migraines.
专利号:US-6417399-B1 优先权日:1997-01-14 标 题:Amelioration of neurological disorders by the administration of (2R),(3S), and/or (2S),3(S) stereoisomers of valnoctamide 发明人:BIALER MEIR; YAGEN BORIS; SPIEGELSTEIN OFER; ROEDER MICHAEL; SCHURIG VOLKER 权利人:YISSUM RES DEV CO 摘要:The present invention generally relates to the individual stereoisomers of the drug valnoctamide (a mixture of four stereoisomer kinds, VCD-valmethamide or 2-ethyl-3-methyl pentanamide) useful in treatment of neurological and psychotic disorders such as different kinds of epilepsy and affective disorders, and useful as tranquilizers and to treat pain, and to pharmaceutical compositions containing, as an active ingredient, these stereoisomers. The present invention further relates to a method for stereoselective separation and quantification of the four stereoisomers from a racemic mixture of VCD or plasma of patients treated with the racemic drug. The present invention further relates to a unique method for the synthesis of the individual stereoisomers.
专利号:US-2008214827-A1 优先权日:2004-02-03 标 题:Synthesis of Cyanoimino-Benzoimidazoles 发明人:GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN 权利人:EURO CELTIQUE SA 摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.
专利号:US-2002156320-A1 优先权日:2000-01-13 标 题 :Enantioselective synthesis of valproic acid analogues 发明人:NAU HEINZ 摘要:This invention employs camphorsultam as a chiral recoverable auxiliary to provide a new method for manufacturing valproic acid and valproic acid amides that facilitates the enantioselective or diasteroselective production of valproic acid analogs on a larger scale.
专利号:CA-2555219-A1 优先权日:2004-02-03 标 题 :Synthesis of cyanoimino-benzoimidazoles
1: M H Subari IAA, Mutthumanickam G, Hj Jikal M, Shah MD, Tan JK, Tan YS, Palasubermaniam P, Palaniveloo K, Sathiya Seelan JS. LC-MS/MS profiling of the poisonous wild mushroom, Entoloma mastoideum, (Entolomataceae, Basidiomycota) in Sabah (Northern Borneo), Malaysia. Toxicon. 2024 Nov 28;251:108133. doi: 10.1016/j.toxicon.2024.108133. Epub 2024 Oct 18. 19(4):e0299198. doi: 10.1371/journal.pone.0299198. 3: Delage C, Palayer M, Etain B, Hagenimana M, Blaise N, Smati J, Chouchana M, Bloch V, Besson VC. Corrigendum to "Valproate, divalproex, valpromide: Are the differences in indications justified?" [Biomed. Pharmacother., 158 (2023) 114051]. Biomed Pharmacother. 2023 Dec;168:115705. doi: 10.1016/j.biopha.2023.115705. Epub 2023 Oct 13. Erratum for: Biomed Pharmacother. 2023 Feb;158:114051. doi: 10.1016/j.biopha.2022.114051. 63:102261. doi: 10.1016/j.legalmed.2023.102261. Epub 2023 Apr 17.
合成参考文献
参考文献:10.1007/bf01962697 摘要:Nau H, Siemes H. Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity. Aspects of species variation, pharmacokinetics, metabolism and implications of structural specificity for the development of alternative antiepileptic agents such as delta 2-valproate. Pharm Weekbl Sci. 1992 Jun 19;14(3A):101–7. doi: 10.1007/bf01962697. 参考文献:10.1007/bf00634242 摘要:Dennis T, Curet O, Nishikawa T, Scatton B. Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission. Naunyn Schmiedebergs Arch Pharmacol. 1985 Nov;331(2-3):225–34. doi: 10.1007/bf00634242. 参考文献:10.1016/j.tiv.2008.04.009 摘要:Luijten M, Verhoef A, Westerman A, Piersma AH. Application of a metabolizing system as an adjunct to the rat whole embryo culture. Toxicol In Vitro. 2008 Aug;22(5):1332–6. doi: 10.1016/j.tiv.2008.04.009. 参考文献:10.1016/j.reprotox.2010.01.009 摘要:Hettwer M, Reis-Fernandes MA, Iken M, Ott M, Steinberg P, Nau H. Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing. Reprod Toxicol. 2010 Aug;30(1):113–20. doi: 10.1016/j.reprotox.2010.01.009.